Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Androstenediol MeSH Descriptor Data 2025


MeSH Heading
Androstenediol
Tree Number(s)
D04.210.500.054.079.429.154.050
D06.472.334.851.968.750
Unique ID
D015114
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015114
Scope Note
An intermediate in TESTOSTERONE biosynthesis, found in the TESTIS or the ADRENAL GLANDS. Androstenediol, derived from DEHYDROEPIANDROSTERONE by the reduction of the 17-keto group (17-HYDROXYSTEROID DEHYDROGENASES), is converted to TESTOSTERONE by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-HYDROXYSTEROID DEHYDROGENASES).
Entry Term(s)
5-Androstene-3,17-diol
5-Androstene-3beta-17beta-Diol
Androst-5-ene-3 beta,17 beta-Diol
Androst-5-ene-3,17-diol
Bisexovister
Delta 5-Androstenediol
Hermaphrodiol
delta 5-Androstene-3 beta,17 beta-Diol
Pharm Action
Anabolic Agents
Registry Numbers
95PS51EMXY
0
Related Numbers
521-17-5
CAS Type 1 Name
Androst-5-ene-3,17-diol, (3beta,17beta)-
Previous Indexing
Androstenediols (1975)
Public MeSH Note
2004; see ANDROST-5-ENE-3 BETA,17 BETA-DIOL 1998-2003, see 5-ANDROSTENE-3,17-DIOL 1991-1997, see ANDROSTENEDIOLS 1976-1990
History Note
2004 (1976); use 5-ANDROSTENE-3,17-DIOL 1991-1997, use ANDROSTENEDIOLS 1976-1990
Date Established
1991/01/01
Date of Entry
1975/07/18
Revision Date
2017/05/24
Androstenediol Preferred
Bisexovister Narrower
page delivered in 0.124s